Matching‐adjusted indirect comparison of isatuximab plus carfilzomib and dexamethasone with daratumumab plus lenalidomide and dexamethasone in relapsed multiple myeloma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5584
Abstract: Lenalidomide‐based regimens are commonly used for early relapse in patients with relapsed and/or refractory multiple myeloma (RRMM) receiving at least one prior line of therapy. In the absence of head‐to‐head comparison, matching‐adjusted indirect comparison (MAIC)… read more here.
Keywords: matching adjusted; indirect comparison; comparison; adjusted indirect ... See more keywords
Indirect comparison of SGLT2 inhibitors in patients with established heart failure: evidence based on Bayesian methods
Sign Up to like & getrecommendations! Published in 2023 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14297
Abstract: Head‐to‐head comparisons among SGLT2 inhibitors treatments in established heart failure remain absent. We conducted a systematic review of dedicated heart failure trials to assess indirectly the composite outcomes and individual clinical endpoints among SGLT2 inhibitor… read more here.
Keywords: heart failure; indirect comparison; established heart; heart ... See more keywords
Assessing the Impact of a Matching Adjusted Indirect Comparison in a Bayesian Network Meta Analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Research synthesis methods"
DOI: 10.1002/jrsm.1372
Abstract: If IPD is available for some or all trials in an NMA, then incorporating this IPD into an NMA is routinely considered to be preferable. However, the situation often arises where a researcher has IPD… read more here.
Keywords: matching adjusted; network; adjusted indirect; indirect comparison ... See more keywords
PD39 First Approach For Assessing Statistical Significance In Industry Funded Matching-Adjusted Indirect Comparison Studies: A Scoping Review
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462324003027
Abstract: Introduction When indirectly compared trials are too heterogeneous to provide a reliable estimate, matching-adjusted indirect comparison (MAIC) studies can be employed. This technique is commonly used for oncology treatments. MAIC is an indirect comparison that… read more here.
Keywords: oncology; matching adjusted; industry; adjusted indirect ... See more keywords
Matching-adjusted indirect comparison of enzalutamide versus darolutamide doublet in mHSPC
Sign Up to like & getrecommendations! Published in 2025 at "Future Oncology"
DOI: 10.1080/14796694.2025.2526324
Abstract: ABSTRACT Aims To compare the efficacy of enzalutamide + androgen-deprivation therapy (ADT) versus darolutamide + ADT for treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) using a matching-adjusted indirect comparison (MAIC). Patients and methods Individual patient data from… read more here.
Keywords: matching adjusted; indirect comparison; darolutamide adt; adjusted indirect ... See more keywords
An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of endourology"
DOI: 10.1089/end.2020.0739
Abstract: Objective This study was designed to provide an indirect comparison of the urinary and sexual domain outcomes and complications following newer minimally invasive surgical therapy (MIST) of Aquablation, Rezum, and UroLift for benign prostatic hyperplasia… read more here.
Keywords: aquablation; analysis; indirect comparison; domain ... See more keywords
Proximal indirect comparison
Sign Up to like & getrecommendations! Published in 2024 at "Biometrika"
DOI: 10.1093/biomet/asaf044
Abstract: We consider the problem of indirect comparison, where a treatment arm of interest is absent by design in one randomized controlled trial but available in the other. The former is the target trial, and the… read more here.
Keywords: comparison; effect; trial; proximal indirect ... See more keywords
Indirect comparison of anti‐interleukin 17 targeted biological treatments for moderate‐to‐severe psoriasis
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13153
Abstract: Psoriasis is an inflammatory skin disease with an important disease burden worldwide and its treatment includes systemic therapies which have advanced over time to target specific immune cytokines such as interleukin‐17. The main objective of… read more here.
Keywords: interleukin targeted; targeted biological; comparison anti; indirect comparison ... See more keywords
Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006280
Abstract: Key Points OS and ORR of tisagenlecleucel were compared with those of historical therapy for r/r DLBCL after ≥2 therapy lines. Tisagenlecleucel was associated with significantly longer OS and higher response rate vs historical therapy. read more here.
Keywords: comparison tisagenlecleucel; indirect comparison; relapsed refractory; tisagenlecleucel historical ... See more keywords
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma
Sign Up to like & getrecommendations! Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2024015274
Abstract: Key Points • In this indirect comparison, epcoritamab significantly improved response and survival vs CIT in patients with relapsed or refractory third-line or higher FL.• Epcoritamab also showed clinically relevant, numerically higher ORRs and improved… read more here.
Keywords: mosunetuzumab odronextamab; epcoritamab; indirect comparison; comparison epcoritamab ... See more keywords
Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2016-0085
Abstract: AIM Using matching-adjusted indirect comparison, we compared efficacy outcomes in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate (DMF) or glatiramer acetate (GA). MATERIALS & METHODS An indirect comparison of DMF (patient-level data)… read more here.
Keywords: matching adjusted; adjusted indirect; multiple sclerosis; indirect comparison ... See more keywords